Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	9.98e-11	11	158	6	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	5.50e-08	14	158	5	GO:0003964
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	4.24e-07	37	158	6	GO:0016891
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25	4.24e-07	37	158	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25	5.00e-07	38	158	6	GO:0070001
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	5.35e-07	21	158	5	GO:0035613
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	1.61e-06	46	158	6	GO:0016893
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 PIWIL4 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	3.06e-06	79	158	7	GO:0004521
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.18e-05	38	158	5	GO:0034061
GeneOntologyMolecularFunction	formyltetrahydrofolate dehydrogenase activity	ALDH1L1 ALDH1L2	6.22e-05	2	158	2	GO:0016155
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 PIWIL4 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	1.06e-04	136	158	7	GO:0004540
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 PIWIL4 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	1.06e-04	136	158	7	GO:0004519
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	TMEM94 ATP13A3 ATP1A1 ATP12A	1.82e-04	36	158	4	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	TMEM94 ATP13A3 ATP1A1 ATP12A	1.82e-04	36	158	4	GO:0015662
GeneOntologyMolecularFunction	aldehyde dehydrogenase (NAD+) activity	ALDH1L1 ALDH1L2 ALDH3A1	2.06e-04	15	158	3	GO:0004029
GeneOntologyMolecularFunction	aldehyde dehydrogenase [NAD(P)+] activity	ALDH1L1 ALDH1L2 ALDH3A1	3.05e-04	17	158	3	GO:0004030
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH1 DNAH17	3.63e-04	18	158	3	GO:0008569
GeneOntologyMolecularFunction	CoA carboxylase activity	ACACB PCCB	9.14e-04	6	158	2	GO:0016421
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERVK-6 PMS2P5 RTEL1 CECR2 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.17e-03	262	158	8	GO:0140097
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	CACNA1E TMEM94 HCN2 RYR3 ITPR3 SLC5A11 P2RX4 SLC28A2 KCNS2 ATP1A1 ATP12A	1.21e-03	465	158	11	GO:0046873
GeneOntologyMolecularFunction	ligase activity, forming carbon-carbon bonds	ACACB PCCB	1.27e-03	7	158	2	GO:0016885
GeneOntologyMolecularFunction	phosphofructokinase activity	PFKFB4 PFKL	1.27e-03	7	158	2	GO:0008443
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 ERVK-7 FPGT ERVK-10 ERVK-8 ERVK-11	1.34e-03	152	158	6	GO:0016779
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH1 DNAH17	1.38e-03	28	158	3	GO:0051959
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	TMEM94 ATP13A3 ATP1A1 ATP12A	1.47e-03	62	158	4	GO:0019829
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA2 TMEM94 ATP13A3 ATP1A1 ATP12A	1.76e-03	109	158	5	GO:0042626
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RYR3 ITPR3 P2RX4	1.86e-03	31	158	3	GO:0099604
GeneOntologyMolecularFunction	O-acetyltransferase activity	LPCAT1 CASD1	2.16e-03	9	158	2	GO:0016413
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	HCN2 RYR3 ITPR3	2.23e-03	33	158	3	GO:0005217
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	CACNA1E TMEM94 ANO10 HCN2 RYR3 ITPR3 SLC5A11 P2RX4 SLC28A2 KCNS2 ATP13A3 ATP1A1 ATP12A	2.43e-03	664	158	13	GO:0008324
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 PIWIL4 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	2.47e-03	231	158	7	GO:0004518
GeneOntologyMolecularFunction	P-type sodium transporter activity	ATP1A1 ATP12A	2.69e-03	10	158	2	GO:0008554
GeneOntologyMolecularFunction	P-type sodium:potassium-exchanging transporter activity	ATP1A1 ATP12A	2.69e-03	10	158	2	GO:0005391
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DNAH1 DNAH17	3.10e-03	37	158	3	GO:0045505
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	2.90e-10	13	157	6	GO:0015074
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 NYNRIN ERVK-8 ERVK-11	1.67e-06	48	157	6	GO:0000731
GeneOntologyBiologicalProcess	NADPH regeneration	ACACB ALDH1L1 MTOR ALDH1L2	3.61e-05	25	157	4	GO:0006740
HumanPheno	Absent sperm flagella	DNHD1 CFAP251 SPEF2 DNAH1 DNAH17	9.92e-06	28	55	5	HP:0032558
HumanPheno	Coiled sperm flagella	DNHD1 CFAP251 SPEF2 DNAH1 DNAH17	1.97e-05	32	55	5	HP:0032560
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	1.69e-06	12	146	4	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	1.69e-06	12	146	4	IPR027970
Domain	ATPase_P-typ_cation-transptr_C	TMEM94 ATP13A3 ATP1A1 ATP12A	7.88e-06	17	146	4	IPR006068
Domain	Cation_ATPase_C	TMEM94 ATP13A3 ATP1A1 ATP12A	7.88e-06	17	146	4	PF00689
Domain	L27_2	MPDZ PATJ	6.07e-05	2	146	2	PF09045
Domain	10_FTHF_DH	ALDH1L1 ALDH1L2	6.07e-05	2	146	2	IPR011407
Domain	L27_2	MPDZ PATJ	6.07e-05	2	146	2	IPR015132
Domain	C8	ZAN BMPER OTOG	9.78e-05	12	146	3	PF08742
Domain	TIL	ZAN BMPER OTOG	9.78e-05	12	146	3	PF01826
Domain	Unchr_dom_Cys-rich	ZAN BMPER OTOG	1.26e-04	13	146	3	IPR014853
Domain	C8	ZAN BMPER OTOG	1.26e-04	13	146	3	SM00832
Domain	TIL_dom	ZAN BMPER OTOG	1.60e-04	14	146	3	IPR002919
Domain	-	ALDH1L1 ALDH1L2	1.81e-04	3	146	2	3.10.25.10
Domain	GART_AS	ALDH1L1 ALDH1L2	1.81e-04	3	146	2	IPR001555
Domain	Formyl_trans_C	ALDH1L1 ALDH1L2	1.81e-04	3	146	2	PF02911
Domain	Formyl_trans_C	ALDH1L1 ALDH1L2	1.81e-04	3	146	2	IPR005793
Domain	GART	ALDH1L1 ALDH1L2	1.81e-04	3	146	2	PS00373
Domain	ATPase_P-typ_transduc_dom_A	TMEM94 ATP13A3 ATP1A1 ATP12A	1.94e-04	37	146	4	IPR008250
Domain	E1-E2_ATPase	TMEM94 ATP13A3 ATP1A1 ATP12A	1.94e-04	37	146	4	PF00122
Domain	VWF_type-D	ZAN BMPER OTOG	2.43e-04	16	146	3	IPR001846
Domain	VWFD	ZAN BMPER OTOG	2.43e-04	16	146	3	PS51233
Domain	ATPase_P-typ_TM_dom	TMEM94 ATP1A1 ATP12A	2.43e-04	16	146	3	IPR023298
Domain	VWD	ZAN BMPER OTOG	2.43e-04	16	146	3	SM00216
Domain	-	TMEM94 ATP1A1 ATP12A	2.43e-04	16	146	3	1.20.1110.10
Domain	Ald_DH_CS_GLU	ALDH1L1 ALDH1L2 ALDH3A1	2.43e-04	16	146	3	IPR029510
Domain	VWD	ZAN BMPER OTOG	2.43e-04	16	146	3	PF00094
Domain	Ald_DH_CS_CYS	ALDH1L1 ALDH1L2 ALDH3A1	2.94e-04	17	146	3	IPR016160
Domain	VWF_dom	ZAN NELL2 BMPER OTOG	3.18e-04	42	146	4	IPR001007
Domain	Cation_ATPase_N	ATP13A3 ATP1A1 ATP12A	3.50e-04	18	146	3	PF00690
Domain	ALDEHYDE_DEHYDR_CYS	ALDH1L1 ALDH1L2 ALDH3A1	3.50e-04	18	146	3	PS00070
Domain	ALDEHYDE_DEHYDR_GLU	ALDH1L1 ALDH1L2 ALDH3A1	3.50e-04	18	146	3	PS00687
Domain	G8_domain	PKHD1L1 PKHD1	3.60e-04	4	146	2	IPR019316
Domain	G8	PKHD1L1 PKHD1	3.60e-04	4	146	2	PS51484
Domain	Carboxyl_trans	ACACB PCCB	3.60e-04	4	146	2	PF01039
Domain	-	ALDH1L1 ALDH1L2	3.60e-04	4	146	2	3.40.50.170
Domain	Formyl_transf_N	ALDH1L1 ALDH1L2	3.60e-04	4	146	2	IPR002376
Domain	COA_CT_CTER	ACACB PCCB	3.60e-04	4	146	2	PS50989
Domain	COA_CT_NTER	ACACB PCCB	3.60e-04	4	146	2	PS50980
Domain	G8	PKHD1L1 PKHD1	3.60e-04	4	146	2	SM01225
Domain	G8	PKHD1L1 PKHD1	3.60e-04	4	146	2	PF10162
Domain	COA_CT_N	ACACB PCCB	3.60e-04	4	146	2	IPR011762
Domain	COA_CT_C	ACACB PCCB	3.60e-04	4	146	2	IPR011763
Domain	Formyl_trans_N	ALDH1L1 ALDH1L2	3.60e-04	4	146	2	PF00551
Domain	Carboxyl_trans	ACACB PCCB	3.60e-04	4	146	2	IPR000022
Domain	-	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	3.40.605.10
Domain	Aldedh	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	PF00171
Domain	VWC_out	ZAN NELL2 OTOG	4.14e-04	19	146	3	SM00215
Domain	Ald_DH_C	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	IPR016163
Domain	Ald_DH_N	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	IPR016162
Domain	Ald_DH/histidinol_DH	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	IPR016161
Domain	ATPase_P-typ_cation-transptr_N	ATP13A3 ATP1A1 ATP12A	4.14e-04	19	146	3	IPR004014
Domain	Aldehyde_DH_dom	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	IPR015590
Domain	-	ALDH1L1 ALDH1L2 ALDH3A1	4.14e-04	19	146	3	3.40.309.10
Domain	-	ALDH1L1 ALDH1L2	5.98e-04	5	146	2	1.10.1200.10
Domain	PHOSPHOPANTETHEINE	ALDH1L1 ALDH1L2	5.98e-04	5	146	2	PS00012
Domain	Formyl_transferase_C-like	ALDH1L1 ALDH1L2	5.98e-04	5	146	2	IPR011034
Domain	INTEGRASE	ERVK-6 NYNRIN	5.98e-04	5	146	2	PS50994
Domain	Integrase_cat-core	ERVK-6 NYNRIN	5.98e-04	5	146	2	IPR001584
Domain	Nlgn	NLGN1 NLGN4X	5.98e-04	5	146	2	IPR000460
Domain	PP-binding	ALDH1L1 ALDH1L2	5.98e-04	5	146	2	PF00550
Domain	ACP_DOMAIN	ALDH1L1 ALDH1L2	5.98e-04	5	146	2	PS50075
Domain	RIH_assoc-dom	RYR3 ITPR3	8.92e-04	6	146	2	IPR013662
Domain	PbH1	PKHD1L1 PKHD1	8.92e-04	6	146	2	SM00710
Domain	Ins145_P3_rec	RYR3 ITPR3	8.92e-04	6	146	2	PF08709
Domain	RIH_assoc	RYR3 ITPR3	8.92e-04	6	146	2	PF08454
Domain	RIH_dom	RYR3 ITPR3	8.92e-04	6	146	2	IPR000699
Domain	Ins145_P3_rcpt	RYR3 ITPR3	8.92e-04	6	146	2	IPR014821
Domain	Ryanodine_recept-rel	RYR3 ITPR3	8.92e-04	6	146	2	IPR015925
Domain	FAT	TRRAP MTOR	8.92e-04	6	146	2	PS51189
Domain	FATC	TRRAP MTOR	8.92e-04	6	146	2	PS51190
Domain	-	RYR3 ITPR3	8.92e-04	6	146	2	1.25.10.30
Domain	FAT	TRRAP MTOR	8.92e-04	6	146	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP MTOR	8.92e-04	6	146	2	IPR003151
Domain	FATC_dom	TRRAP MTOR	8.92e-04	6	146	2	IPR003152
Domain	RYDR_ITPR	RYR3 ITPR3	8.92e-04	6	146	2	PF01365
Domain	PbH1	PKHD1L1 PKHD1	8.92e-04	6	146	2	IPR006626
Domain	P-type_ATPase_IIC	ATP1A1 ATP12A	8.92e-04	6	146	2	IPR005775
Domain	PIK_FAT	TRRAP MTOR	8.92e-04	6	146	2	IPR014009
Domain	PP-bd_ACP	ALDH1L1 ALDH1L2	8.92e-04	6	146	2	IPR009081
Domain	FATC	TRRAP MTOR	8.92e-04	6	146	2	SM01343
Domain	Integrin_dom	ITGAE ITGAX ITGB5	9.49e-04	25	146	3	IPR032695
Domain	VWF_A	ITGAE ITGAX ITGB5 SEC24D HMCN2	1.08e-03	99	146	5	IPR002035
Domain	Pectin_lyase_fold/virulence	PKHD1L1 PKHD1	1.65e-03	8	146	2	IPR011050
Domain	-	ATP13A3 ATP1A1 ATP12A	1.97e-03	32	146	3	3.40.1110.10
Domain	-	ATP13A3 ATP1A1 ATP12A	1.97e-03	32	146	3	2.70.150.10
Domain	Ion_trans_dom	CACNA1E HCN2 RYR3 ITPR3 KCNS2	2.02e-03	114	146	5	IPR005821
Domain	Ion_trans	CACNA1E HCN2 RYR3 ITPR3 KCNS2	2.02e-03	114	146	5	PF00520
Domain	ATPase_P-typ_cyto_domN	ATP13A3 ATP1A1 ATP12A	2.55e-03	35	146	3	IPR023299
Domain	MIR	RYR3 ITPR3	2.62e-03	10	146	2	PF02815
Domain	MIR_motif	RYR3 ITPR3	2.62e-03	10	146	2	IPR016093
Domain	MIR	RYR3 ITPR3	2.62e-03	10	146	2	PS50919
Domain	MIR	RYR3 ITPR3	2.62e-03	10	146	2	SM00472
Domain	VWFC_1	ZAN NELL2 BMPER	2.77e-03	36	146	3	PS01208
Domain	ATPase_P-typ_P_site	ATP13A3 ATP1A1 ATP12A	2.77e-03	36	146	3	IPR018303
Domain	P_typ_ATPase	ATP13A3 ATP1A1 ATP12A	2.77e-03	36	146	3	IPR001757
Domain	ATPASE_E1_E2	ATP13A3 ATP1A1 ATP12A	2.77e-03	36	146	3	PS00154
Domain	Integrin_alpha	ITGAE ITGAX	3.19e-03	11	146	2	PF00357
Domain	VWFC_2	ZAN NELL2 BMPER	3.23e-03	38	146	3	PS50184
Domain	VWC	ZAN NELL2 BMPER	3.23e-03	38	146	3	SM00214
Domain	Olfact_rcpt	OR4D6 OR6C65 OR11H12 OR4D2 OR4C15 OR11H1 OR6C4 OR6C75 OR6K3	3.80e-03	393	146	9	IPR000725
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	6.42e-09	6	160	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	6.42e-09	6	160	4	25930072
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25 ERVK-11	2.80e-07	94	160	7	21542922
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PMS2P2 INTU RASA1 RTEL1 PFKFB4 PFKL CERT1 TRRAP ITGB5 TASOR2 DNAH1 TYK2 SCARB1 LMLN CSTF3 RIPOR1 LRRC7 LIMCH1 PATJ GPT2 LSM7 VPS13B ADGRD1	3.72e-07	1489	160	23	28611215
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10	3.81e-07	4	160	3	10469592
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18	9.49e-07	5	160	3	12629516
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-10 ERVK-18 ERVK-25 ERVK-11	1.26e-06	18	160	4	18664271
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ACACB TOPAZ1 ALDH1L1 ME1 TRRAP SPATA31A6 TGM5 RYR3 LIMCH1 ATP1A1 HERC1 DNPEP	3.62e-06	497	160	12	36774506
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 TMEM94 FBXL12 NUBPL TRRAP FAAP100 ITGB5 MAP3K5 ITPR3 TYK2 CNPPD1 MTOR SCARB1 A4GALT RIPOR1 GPC2 HERC1 MVB12B	3.71e-06	1105	160	18	35748872
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	4.27e-06	24	160	4	32212159
Pubmed	Genetic control of leucocyte--endothelial cell interaction in collagen-induced arthritis.	SELL IL13RA1 IL1B	1.12e-05	10	160	3	20223839
Pubmed	RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.	RASA1 NF1	2.10e-05	2	160	2	29127119
Pubmed	Tumor-secreted factors induce IL-1β maturation via the glucose-mediated synergistic axis of mTOR and NF-κB pathways in mouse macrophages.	MTOR IL1B	2.10e-05	2	160	2	30586442
Pubmed	The murine vik gene (chromosome 9) encodes a putative receptor with unique protein kinase motifs.	ME1 RYK	2.10e-05	2	160	2	8380921
Pubmed	SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.	SF3B3 MTOR	2.10e-05	2	160	2	38671459
Pubmed	Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.	P2RX4 MTOR	2.10e-05	2	160	2	36385525
Pubmed	Relocation of phosphofructokinases within epithelial cells is a novel event preceding breast cancer recurrence that accurately predicts patient outcomes.	PFKFB4 PFKL	2.10e-05	2	160	2	34348486
Pubmed	PATJ and MPDZ are required for trophectoderm lineage specification in early mouse embryos.	MPDZ PATJ	2.10e-05	2	160	2	37318097
Pubmed	A Significant Difference in Core PDZ Interactivity of SARS-CoV, SARS-CoV2 and MERS-CoV Protein E Peptide PDZ Motifs In Vitro.	MPDZ PATJ	2.10e-05	2	160	2	36932261
Pubmed	Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.	RASA1 NF1	2.10e-05	2	160	2	12730209
Pubmed	Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.	NF1 MTOR	2.10e-05	2	160	2	21748792
Pubmed	[Presence of a male sterility factor, Hst-2, segregating in interspecies crosses. M. musculus L. x M. spretus Lastaste and linked to Mod-1, and Mpi-1 on chromosome 9].	ME1 MPI	2.10e-05	2	160	2	6812867
Pubmed	Characterization of the cytoplasmic domain of interleukin-13 receptor-alpha.	IL13RA1 TYK2	2.10e-05	2	160	2	10409622
Pubmed	ALDH1L2 is the mitochondrial homolog of 10-formyltetrahydrofolate dehydrogenase.	ALDH1L1 ALDH1L2	2.10e-05	2	160	2	20498374
Pubmed	CD11c(+) CD103(+) cells of Mycobacterium tuberculosis-infected C57BL/6 but not of BALB/c mice induce a high frequency of interferon-γ- or interleukin-17-producing CD4(+) cells.	ITGAE ITGAX	2.10e-05	2	160	2	25322675
Pubmed	CD103 Regulates Dermal Regulatory T Cell Motility and Interactions with CD11c-Expressing Leukocytes to Control Skin Inflammation.	ITGAE ITGAX	2.10e-05	2	160	2	37341508
Pubmed	Treponemapallidum Dysregulates Monocytes and Promotes the Expression of IL-1β and Migration in Monocytes Through the mTOR Signaling Pathway.	MTOR IL1B	2.10e-05	2	160	2	33282751
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	2.10e-05	2	160	2	11672541
Pubmed	Tbx6 controls left-right asymmetry through regulation of Gdf1.	DAND5 RFX3 WNT5B	2.64e-05	13	160	3	29650695
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	MBTD1 TMEM94 FBXL12 FAM91A1 ANO10 ERVK-10 FAAP100 RYK TASOR2 FREM2 NF1 NLGN4X ARSL RIPOR1 ERVK-25 ZBTB18 DNPEP	4.83e-05	1215	160	17	15146197
Pubmed	Acyl carrier protein-specific 4'-phosphopantetheinyl transferase activates 10-formyltetrahydrofolate dehydrogenase.	ALDH1L1 ALDH1L2	6.29e-05	3	160	2	19933275
Pubmed	Linkage of the structural gene for uroporphyrinogen I synthase to markers on mouse chromosome 9 in a cross between feral and inbred mice.	ME1 MPI	6.29e-05	3	160	2	7138495
Pubmed	Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.	RASA1 NF1	6.29e-05	3	160	2	26002977
Pubmed	Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein.	RASA1 NF1	6.29e-05	3	160	2	7477259
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-11	6.29e-05	3	160	2	9971820
Pubmed	The genes coding for pyruvate kinase (M2) and mannosephosphate isomerase are linked in man and mouse.	ME1 MPI	6.29e-05	3	160	2	752545
Pubmed	[Genetic studies of primary open-angle glaucoma].	WDR36 MYOC	6.29e-05	3	160	2	25711070
Pubmed	Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells.	MPDZ PATJ	6.29e-05	3	160	2	12403818
Pubmed	Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms.	ITGB5 IL1B	6.29e-05	3	160	2	18276918
Pubmed	Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase.	ALDH1L1 ALDH1L2	6.29e-05	3	160	2	21238436
Pubmed	[Genetic variants of CYP1B1 and WDR36 in the patients with primary congenital glaucoma and primary open angle glaucoma from Saint-Petersburg].	WDR36 MYOC	6.29e-05	3	160	2	20198978
Pubmed	A Transposon-based Analysis Reveals RASA1 Is Involved in Triple-Negative Breast Cancer.	RASA1 NF1	6.29e-05	3	160	2	28108518
Pubmed	Elucidating the mechanism of IL-1β-Mediated Piezo1 expression regulation of chondrocyte autophagy and apoptosis via the PI3K/AKT/mTOR signaling Pathway.	MTOR IL1B	6.29e-05	3	160	2	38134572
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18	6.29e-05	3	160	2	10516026
Pubmed	Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.	MAP3K5 MTOR	6.29e-05	3	160	2	15218033
Pubmed	Application of the ovarian teratoma mapping method in the mouse.	ME1 MPI	6.29e-05	3	160	2	6852526
Pubmed	Similar and distinct properties of MUPP1 and Patj, two homologous PDZ domain-containing tight-junction proteins.	MPDZ PATJ	6.29e-05	3	160	2	19255144
Pubmed	The serotonin 5-HT1B receptor subtype (Htr1b) gene maps to mouse chromosome 9.	ME1 MPI	6.29e-05	3	160	2	8358175
Pubmed	Tg (9 HSA-MYC), a homozygous lethal insertion in the mouse.	ME1 MPI	6.29e-05	3	160	2	1797233
Pubmed	Sucrose, But Not Glucose, Blocks IL1-β-Induced Inflammatory Response in Human Chondrocytes by Inducing Autophagy via AKT/mTOR Pathway.	MTOR IL1B	6.29e-05	3	160	2	27669541
Pubmed	Esterase-17 (ES-17): characterization and genetic location on chromosome 9 of a bis-p-nitrophenyl phosphate-resistant esterase of the house mouse (Mus musculus).	ME1 MPI	6.29e-05	3	160	2	6838491
Pubmed	Effects of timolol on MYOC, OPTN, and WDR36 RNA levels.	WDR36 MYOC	6.29e-05	3	160	2	18195223
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TMEM94 NUBPL NF1 NLGN4X MTOR SCARB1 EHD1 ATP13A3 ATP1A1 PATJ VPS13B	7.06e-05	569	160	11	30639242
Pubmed	An investigation into the human serum "interactome".	SPEF2 SPATA31A7 ERVK-10 ITGB5 AP4E1 SACS	1.09e-04	162	160	6	15174051
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	INTU TMEM94 FAM91A1 NLGN1 CSMD3 RIPOR1 LRRC7 LIMCH1 VPS13B	1.20e-04	407	160	9	12693553
Pubmed	Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.	RYR3 ITPR3	1.25e-04	4	160	2	22100703
Pubmed	Multiple gene polymorphisms analysis revealed a different profile of genetic polymorphisms of primary open-angle glaucoma in northern Chinese.	WDR36 MYOC	1.25e-04	4	160	2	19145250
Pubmed	MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.	NF1 MTOR	1.25e-04	4	160	2	24509877
Pubmed	Glaucomatous MYOC mutations activate the IL-1/NF-κB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells.	MYOC IL1B	1.25e-04	4	160	2	26396484
Pubmed	Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.	RASA1 NF1	1.25e-04	4	160	2	11246230
Pubmed	Localization of cytochrome P1-450 and P3-450 genes to mouse chromosome 9.	ME1 MPI	1.25e-04	4	160	2	6328503
Pubmed	p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.	NF1 MTOR	1.25e-04	4	160	2	29392777
Pubmed	Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia.	CHGA IL1B	1.25e-04	4	160	2	23831373
Pubmed	Location of the gene for theta antigen in the mouse. III. The position of Thy-1 relative to Lap-1 and Mpi-1.	ME1 MPI	1.25e-04	4	160	2	314952
Pubmed	Polymorphism and linkage for mannosephosphate isomerase in Mus musculus.	ME1 MPI	1.25e-04	4	160	2	4693062
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN1 NLGN4X	1.25e-04	4	160	2	16077734
Pubmed	Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex.	MTOR IL1B	1.25e-04	4	160	2	25418470
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10	1.25e-04	4	160	2	7983737
Pubmed	TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing.	PIWIL4 TASOR2	1.25e-04	4	160	2	32719317
Pubmed	[Modification of Levels of Adhesion Molecule Expression of Human Innate Immune Cells by Glycopolymers of Marine Bacteria].	SELL ITGAX	1.25e-04	4	160	2	26852488
Pubmed	Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.	ALDH1L1 ALDH1L2 ALDH3A1	1.58e-04	23	160	3	18971422
Pubmed	Variants in the 1q21 risk region are associated with a visual endophenotype of autism and schizophrenia.	OR6C65 OR6C4 OR6C75	1.80e-04	24	160	3	24152035
Pubmed	The DNA sequence, annotation and analysis of human chromosome 3.	ZNF717 NLGN1 ATP13A3 ERVK-11	1.96e-04	62	160	4	16641997
Pubmed	Multiple genes encode the human Na+,K+-ATPase catalytic subunit.	ATP1A1 ATP12A	2.08e-04	5	160	2	3035563
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7	2.08e-04	5	160	2	11401426
Pubmed	Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.	NLGN1 NLGN4X	2.08e-04	5	160	2	15620359
Pubmed	A serum protein polymorphism determinant on chromosome 9 of Mus musculus.	ME1 MPI	2.08e-04	5	160	2	6929943
Pubmed	A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis.	SELL ITGAE	2.08e-04	5	160	2	18250468
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN1 NLGN4X	2.08e-04	5	160	2	37865312
Pubmed	Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance.	ITGAE ITGAX	2.08e-04	5	160	2	23733880
Pubmed	The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence.	PKHD1L1 PKHD1	2.08e-04	5	160	2	20048263
Pubmed	Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.	SELL ITGB5	2.08e-04	5	160	2	14718670
Pubmed	Structural analysis of the RZZ complex reveals common ancestry with multisubunit vesicle tethering machinery.	KNTC1 NBAS	2.08e-04	5	160	2	20462495
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN1 NLGN4X	2.08e-04	5	160	2	10996085
Pubmed	Ouabain inhibits tubuloglomerular feedback in mutant mice with ouabain-sensitive alpha1 Na,K-ATPase.	ATP1A1 ATP12A	2.08e-04	5	160	2	16870707
Pubmed	Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation.	MTOR ATP1A1	2.08e-04	5	160	2	29321306
Pubmed	Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor.	ADRM1 ITPR3 HERC1 LSM7	2.35e-04	65	160	4	28276505
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	ITGAE ITGAX ITGB5	2.58e-04	27	160	3	31541017
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN1 NLGN4X	3.12e-04	6	160	2	21838267
Pubmed	The family of human Na+,K+-ATPase genes. No less than five genes and/or pseudogenes related to the alpha-subunit.	ATP1A1 ATP12A	3.12e-04	6	160	2	3036582
Pubmed	Transcription factor AP-2β regulates the neurotransmitter phenotype and maturation of chromaffin cells.	DBH CHGA	3.12e-04	6	160	2	20875861
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR3 ITPR3	3.12e-04	6	160	2	23463619
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR3 ITPR3	3.12e-04	6	160	2	25966694
Pubmed	The isolation and mapping of PCR markers specific to mouse Chromosome 2.	DBH IL1B	3.12e-04	6	160	2	8835533
Pubmed	Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties.	MPDZ PATJ	3.12e-04	6	160	2	17397395
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN1 NLGN4X	3.12e-04	6	160	2	29724786
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR3 ITPR3	3.12e-04	6	160	2	20519450
Pubmed	Multiple CD11c+ cells collaboratively express IL-1β to modulate stromal vascular endothelial growth factor and lymph node vascular-stromal growth.	ITGAX IL1B	3.12e-04	6	160	2	24659690
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR3 ITPR3	3.12e-04	6	160	2	16844763
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	CACNA1E NLGN1 NF1 NLGN4X SACS MTOR LRRC7	3.40e-04	281	160	7	28706196
Cytoband	5q13.3	RASA1 CERT1 PDE8B	2.51e-04	35	160	3	5q13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	3.33e-04	8	160	2	chr9q12
GeneFamily	Aldehyde dehydrogenases	ALDH1L1 ALDH1L2 ALDH3A1	1.20e-04	19	93	3	398
GeneFamily	Olfactory receptors, family 6	OR6C65 OR6C4 OR6C75 OR6K3	1.36e-04	51	93	4	153
GeneFamily	PDZ domain containing\|Crumbs complex	MPDZ PATJ	9.20e-04	9	93	2	1223
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	SELL MASP1 CSMD3	3.15e-03	57	93	3	1179
GeneFamily	Dyneins, axonemal	DNAH1 DNAH17	3.39e-03	17	93	2	536
GeneFamily	Aminopeptidases\|CD molecules	LAP3 DNPEP	3.39e-03	17	93	2	104
GeneFamily	Sulfatases	ARSL GNS	3.80e-03	18	93	2	410
GeneFamily	CD molecules\|Integrin alpha subunits	ITGAE ITGAX	3.80e-03	18	93	2	1160
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN NLGN1 CSMD3 PKHD1L1 RYR3 DNAH1 PKHD1 ATP12A	1.24e-07	169	152	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN CSMD3 PKHD1L1 RYR3 DNAH1 FREM2 PKHD1 OTOG	2.38e-07	184	152	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN CSMD3 PKHD1L1 RYR3 DNAH1 FREM2 PKHD1 OTOG	2.38e-07	184	152	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN CSMD3 PKHD1L1 RYR3 DNAH1 FREM2 PKHD1 OTOG	2.38e-07	184	152	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 CECR2 NLGN1 ME1 MAP3K5 PKHD1 LIMCH1 PATJ	2.70e-07	187	152	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZAN CSMD3 PKHD1L1 FREM2 PKHD1 LRRC7 ATP12A	1.44e-06	162	152	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA1 INTU MPDZ CERT1 AP4E1 LIMCH1 GPC2	1.50e-06	163	152	7	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 MAP3K5 PKHD1 LIMCH1 PATJ	2.59e-06	177	152	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TNPO2 TAB3 DNAH1 RIPOR1 LIMCH1 GPT2 ZBTB18	2.90e-06	180	152	7	62511d76d24b836839c3dcc2bf30485ffe9401e2
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TNPO2 TAB3 DNAH1 RIPOR1 LIMCH1 GPT2 ZBTB18	3.12e-06	182	152	7	03992d0ae519795239e4f2cc8e63f33c4482de6a
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 CECR2 NLGN1 FREM2 NELL2 LIMCH1 PATJ	3.47e-06	185	152	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E IL13RA1 CPED1 SEC24D ALDH1L2 A4GALT HCRTR2	3.47e-06	185	152	7	e583f6601f9ed79b0b23d2f9426a4ba8b969230b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LPCAT1 ITPR3 FREM2 PKHD1 LIMCH1 ATP1A1 PATJ	3.73e-06	187	152	7	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	COPD-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	SELL LPCAT1 ITGAX SRGAP1 EHD1 ATP13A3 IL1B	4.00e-06	189	152	7	6294691231c7d38707323cf31578a107d3b2c622
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LPCAT1 ITPR3 FREM2 PKHD1 LIMCH1 ATP1A1 PATJ	4.28e-06	191	152	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LPCAT1 ITPR3 FREM2 PKHD1 LIMCH1 ATP1A1 PATJ	4.43e-06	192	152	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	IL13RA1 HLA-DMA CPED1 ITGB5 CD163L1 SRGAP1 IL1B	5.61e-06	199	152	7	96070b5ffcbab4952970f43b536969ddd2ca5d14
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MASP1 PFKFB4 DNAH1 FANCB LMLN LIMCH1	1.39e-05	152	152	6	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MASP1 PFKFB4 DNAH1 FANCB LMLN LIMCH1	1.39e-05	152	152	6	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	ACACB MYOC CPED1 RYR3 HMCN2 ADGRD1	1.86e-05	160	152	6	8a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell	TCGA-Bladder-Solid_Tissue_Normal\|TCGA-Bladder / Sample_Type by Project: Shred V9	ACACB MYOC CPED1 RYR3 HMCN2 ADGRD1	1.86e-05	160	152	6	d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	ACACB MYOC CPED1 RYR3 HMCN2 ADGRD1	1.86e-05	160	152	6	c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|390C / Donor, Lineage, Cell class and subclass (all cells)	RASA1 ITGAX P2RX4 NYNRIN LRRC7 GPC2	2.62e-05	170	152	6	439167e44a1bd5ac8e1e457351dd202ec968db46
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMA CHGA ITGAX ITGB5 P2RX4 GNS	2.62e-05	170	152	6	067657ca7fcf5a0ffbd168b5c4609a30ca508f22
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELL THEMIS ITGAE CD163L1 SLC28A2 PKHD1	2.71e-05	171	152	6	801893c318f7b1abc8d97bac86a00974f910a71c
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1E NLGN1 ALDH1L1 SLC5A11 FREM2 PKHD1	3.39e-05	178	152	6	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	3.50e-05	179	152	6	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	INTU ITGAX ITGB5 CD163L1 SRGAP1 IL1B	3.61e-05	180	152	6	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	3.72e-05	181	152	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	COVID-19-kidney-Stressed_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1E NLGN1 SLC5A11 FREM2 PKHD1 GPT2	3.72e-05	181	152	6	6980ea624151da32b7f537f263e40fcb87a02e81
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	4.08e-05	184	152	6	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 CECR2 NLGN1 FREM2 NELL2 PATJ	4.08e-05	184	152	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	(7)_DC_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	IL13RA1 WNT5B NELL2 PDE8B SRGAP1 LIMCH1	4.08e-05	184	152	6	b89871a3e36fde6daa68daf116f8c8d587554c0f
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	4.20e-05	185	152	6	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	4.33e-05	186	152	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CECR2 NLGN1 ME1 PKHD1 LIMCH1 PATJ	4.33e-05	186	152	6	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFAP251 HLA-DMA ITGAE PKHD1L1 A4GALT LSM7	4.60e-05	188	152	6	9a10536afa2dea34c78421d36564cfd8252afe45
ToppCell	COVID-19-kidney-DCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GCGR ALDH1L1 FREM2 PKHD1 ATP1A1 PATJ	4.60e-05	188	152	6	1d56cd409793f05cca20757ab26e91f1a1ee67b5
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	4.87e-05	190	152	6	4b25d49f033bbd326b47cf5602af3f0262cfc367
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|B_lymphocytes / Location, Cell class and cell subclass	CFAP251 HLA-DMA ITGAE PDE8B SCARB1 A4GALT	4.87e-05	190	152	6	c5c80a6b9087821a2e07250fa90bcd3505f103b6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NLGN1 WNT5B SEC24D HMCN2 ALDH1L2 LRRC7	5.17e-05	192	152	6	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	LPCAT1 CECR2 ITPR3 FREM2 LIMCH1 PATJ	5.17e-05	192	152	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LPCAT1 ITPR3 FREM2 PKHD1 LIMCH1 PATJ	5.17e-05	192	152	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.17e-05	192	152	6	8e606eae3e5b07a856d3c2a74186d486da96309c
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LPCAT1 ITPR3 FREM2 PKHD1 LIMCH1 PATJ	5.32e-05	193	152	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INTU CFAP251 SPEF2 EFHB C11orf16 RFX3	5.47e-05	194	152	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	droplet-Lung-1m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PFKFB4 TMBIM6 ITGAX ATP13A3 PATJ GNS	5.47e-05	194	152	6	d16ab5f0cfe73afe6c551fd3123d14784a082f56
ToppCell	(010)_cDC\|World / immune cells in Peripheral Blood (logTPM normalization)	IL13RA1 HLA-DMA CPED1 ITGAX ITGB5 LIMCH1	5.63e-05	195	152	6	4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCell	ILEUM-non-inflamed-(3)_moDC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IL13RA1 HLA-DMA ITGAX CD163L1 SRGAP1 IL1B	5.79e-05	196	152	6	e10f01172fd076d6892906853f9375d4c3058951
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP251 SPEF2 ALDH1L1 EFHB C11orf16 RFX3	5.96e-05	197	152	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	(6)_Macrophage\|World / shred on Cell_type and subtype	IL13RA1 ITGAX ITGB5 NELL2 CD163L1 IL1B	5.96e-05	197	152	6	010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP251 SPEF2 ALDH1L1 EFHB C11orf16 RFX3	5.96e-05	197	152	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INTU CFAP251 SPEF2 MPDZ RFX3 LMLN	5.96e-05	197	152	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP251 SPEF2 ALDH1L1 EFHB C11orf16 RFX3	5.96e-05	197	152	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	PBMC-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.96e-05	197	152	6	22e4ffb5de483eaf78f14badf3d08db898e3b3dd
ToppCell	PBMC-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.96e-05	197	152	6	346974c6c5809a3fe88cbf067e2d64c340310a31
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP251 SPEF2 ALDH1L1 EFHB C11orf16 RFX3	5.96e-05	197	152	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	PBMC-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.96e-05	197	152	6	1ae45c1ec3b3f88e0c1f99de58c58b1ec1b968ee
ToppCell	COVID-19_Severe-Myeloid-cDC\|COVID-19_Severe / Disease group, lineage and cell class	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.96e-05	197	152	6	843b0f1cc26864ee635df7938c77552ee06fe00b
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LPCAT1 CECR2 ITPR3 FREM2 LIMCH1 ADGRD1	5.96e-05	197	152	6	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	5.96e-05	197	152	6	f78f44dcd7855c96f148678c1f416075aef71b4e
ToppCell	control-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IL13RA1 HLA-DMA CPED1 ITGAX LIMCH1 IL1B	6.30e-05	199	152	6	31825ba336603fe940dea6022e18ec25af110f4c
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac\|GI_small-bowel / Manually curated celltypes from each tissue	IL13RA1 HLA-DMA CPED1 ITGB5 CD163L1 IL1B	6.30e-05	199	152	6	8990a3d69e24cb3aaba9d6def3d0be9ee973436d
ToppCell	Sigmoid-T_cell-Tcm\|T_cell / Region, Cell class and subclass	SELL IL13RA1 SF3B3 MTOR PDE8B OR6C75	6.30e-05	199	152	6	acdf95f4d58df47690f4ae254245bc618f9ac07e
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Transverse / Region, Cell class and subclass	IL13RA1 PFKFB4 ME1 ITGB5 IL1B GNS	6.30e-05	199	152	6	facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCell	Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage\|Transverse / shred on region, Cell_type, and subtype	IL13RA1 PFKFB4 ME1 ITGB5 IL1B GNS	6.30e-05	199	152	6	dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LPCAT1 ITPR3 FREM2 LIMCH1 ATP1A1 ADGRD1	6.30e-05	199	152	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	WDR36 MAP3K5 SRGAP1 ATP13A3 LIMCH1 ADGRD1	6.30e-05	199	152	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E NELL2 SRGAP1 LIMCH1 ZBTB18 RAI2	6.48e-05	200	152	6	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	mild-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	6.48e-05	200	152	6	86f585bf9066b179bbcbc703bf43f15da4a07284
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD14\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SELL ITGAX DNAH17 EHD1 ATP13A3 IL1B	6.48e-05	200	152	6	54221271becd02a4ffa826e06c8e76fcd2651d50
ToppCell	Sigmoid-Macrophage-Macrophage\|Sigmoid / Region, Cell class and subclass	IL13RA1 ITGAX ITGB5 CD163L1 SRGAP1 IL1B	6.48e-05	200	152	6	9ee3a799de7bade1bfe94b6827461633f02bc1dc
ToppCell	Sigmoid-(5)_Dendritic_cell-(51)_cDC1\|Sigmoid / shred on region, Cell_type, and subtype	CECR2 NUBPL TGM5 PDE8B LIMCH1 MVB12B	6.48e-05	200	152	6	4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	LPCAT1 CECR2 ME1 PKHD1 LIMCH1 PATJ	6.48e-05	200	152	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	ALDH1L1 WNT5B ALDH1L2 SRGAP1 ATP12A GPT2	6.48e-05	200	152	6	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	COVID-19-COVID-19_Severe-Myeloid-cDC\|COVID-19_Severe / Disease, condition lineage and cell class	IL13RA1 HLA-DMA CPED1 ITGAX LAP3 LIMCH1	6.48e-05	200	152	6	e7b808d8ed65343a4345fafb03015fe4f7ce302f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1E ALDH1L1 ALDH1L2 SRGAP1 ATP12A GPT2	6.48e-05	200	152	6	ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal\|3m / Sample Type, Dataset, Time_group, and Cell type.	CHGA NELL2 SRGAP1 LRRC7 GPC2 ZBTB18	6.48e-05	200	152	6	af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCell	Sigmoid-Macrophage\|Sigmoid / Region, Cell class and subclass	IL13RA1 ITGAX ITGB5 CD163L1 SRGAP1 IL1B	6.48e-05	200	152	6	b07ac0ff3b8530e99094678fed80f35949cafac8
ToppCell	Sigmoid-(6)_Macrophage-(60)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	IL13RA1 ITGAX ITGB5 CD163L1 SRGAP1 IL1B	6.48e-05	200	152	6	ad84a83a5a1893f7b053d39eddeca851463a8ff0
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Sigmoid / Region, Cell class and subclass	CECR2 NUBPL TGM5 PDE8B LIMCH1 MVB12B	6.48e-05	200	152	6	3523ec986e8c9e176e08836c974b1de8b56d8b16
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E NELL2 SRGAP1 LIMCH1 ZBTB18 RAI2	6.48e-05	200	152	6	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IL13RA1 HLA-DMA CPED1 ITGAX LIMCH1 IL1B	6.48e-05	200	152	6	4a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	NUBPL TGM5 PDE8B LIMCH1 GPT2 MVB12B	6.48e-05	200	152	6	09deb831fc2c8a8867cc850f3aa094a5e48489ff
ToppCell	Sigmoid-(6)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	IL13RA1 ITGAX ITGB5 CD163L1 SRGAP1 IL1B	6.48e-05	200	152	6	9e10cca4429de2c4c8c3c6cf2c9e28637a095be9
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1E ALDH1L1 ALDH1L2 SRGAP1 ATP12A GPT2	6.48e-05	200	152	6	85c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCell	(60)_Macrophage\|World / shred on Cell_type and subtype	IL13RA1 ITGAX ITGB5 NELL2 CD163L1 IL1B	7.22e-05	204	152	6	06d0cb306f1ad0014d81f8228868938e48c2bcf3
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MASP1 ABCA2 RYR3 WDR91 HMCN2	7.80e-05	128	152	5	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TOPAZ1 NOX3 CSMD3 SPATA31A6 PKHD1	8.40e-05	130	152	5	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	INTU PFKFB4 ARSL SLC28A2 LIMCH1	1.04e-04	136	152	5	5e209185b5f6e9347829fc9066f0b2c3711df057
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MYOC NLGN1 DNAH1 CD163L1 RAI2	1.08e-04	137	152	5	b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	NLGN1 DNAH1 HMCN2 TESK2 ADGRD1	1.08e-04	137	152	5	a69976938d4e89315ec0be3a332b91ddf3799d65
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RASA1 FBXL12 PATJ	1.16e-04	28	152	3	456cf2e0a6ea59c279efc77a1d02e5572196cb6b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IL13RA1 ITGB5 SLC5A11 HMCN2 SRGAP1	1.19e-04	140	152	5	2c44e8cc5190226049be7ebc465d685393e701c4
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2\|TCGA-Bladder / Sample_Type by Project: Shred V9	MYOC CPED1 RYR3 HMCN2 ADGRD1	1.23e-04	141	152	5	1baa054c2ae3b446d1954244b7fbf8af824ef345
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GCGR WNT5B FREM2 NYNRIN ADGRD1	1.31e-04	143	152	5	27e06327f96cb72bd111ea6ece6307e5ebb3a146
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GCGR WNT5B FREM2 NYNRIN ADGRD1	1.31e-04	143	152	5	4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELL THEMIS ITGAE CD163L1 SLC28A2	1.40e-04	145	152	5	a9f5a32abcf3eb2c66bd65f2521a6dd4ce56c635
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 FREM2 PKHD1 LRRC7 ATP12A	1.40e-04	145	152	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELL THEMIS ITGAE CD163L1 SLC28A2	1.59e-04	149	152	5	4fda987bc7bb6d1dbd41b8f1f8c1bc59613255a8
Computational	Genes in the cancer module 412.	ITGAE ITGAX ITGB5	1.16e-04	13	82	3	MODULE_412
Disease	Pheochromocytoma, Extra-Adrenal	DBH CHGA NF1	5.60e-05	16	140	3	C1257877
Disease	Intellectual Disability	CACNA1E TMEM94 CERT1 TRRAP AP4E1 NF1 SACS MTOR ATP1A1 GPT2	5.73e-05	447	140	10	C3714756
Disease	Pheochromocytoma	DBH CHGA NF1	9.58e-05	19	140	3	C0031511
Disease	crescentic glomerulonephritis (implicated_via_orthology)	MTOR IL1B	3.31e-04	6	140	2	DOID:13139 (implicated_via_orthology)
Disease	Glaucoma	WDR36 MYOC	3.31e-04	6	140	2	cv:C0017601
Disease	X-13553 measurement	DBH ARSL	3.31e-04	6	140	2	EFO_0021355
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 FPGT CSMD3 MTOR SCARB1	3.71e-04	128	140	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 FPGT CSMD3 MTOR SCARB1	3.71e-04	128	140	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 FPGT CSMD3 MTOR SCARB1	3.71e-04	128	140	5	C1266044
Disease	Papillary Renal Cell Carcinoma	DNHD1 FPGT CSMD3 MTOR SCARB1	3.71e-04	128	140	5	C1306837
Disease	Renal Cell Carcinoma	DNHD1 FPGT CSMD3 MTOR SCARB1	3.71e-04	128	140	5	C0007134
Disease	IgA glomerulonephritis (is_implicated_in)	SELL CHGA IL1B	3.86e-04	30	140	3	DOID:2986 (is_implicated_in)
Disease	Ovarian Mucinous Adenocarcinoma	TRRAP RYK MTOR	4.26e-04	31	140	3	C1335167
Disease	Global developmental delay	CACNA1E TMEM94 TRRAP NBAS ZBTB18	4.42e-04	133	140	5	C0557874
Disease	recalcitrant atopic dermatitis	THEMIS NBAS	4.62e-04	7	140	2	EFO_1000651
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP12A	4.62e-04	7	140	2	DOID:0060178 (implicated_via_orthology)
Disease	sleep duration, circadian rhythm, excessive daytime sleepiness measurement, insomnia measurement	PATJ HCRTR2	6.14e-04	8	140	2	EFO_0004354, EFO_0005271, EFO_0007875, EFO_0007876
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 FPGT CSMD3 MTOR SCARB1	7.19e-04	148	140	5	C0279702
Disease	asparagine measurement	PIWIL4 CERT1 RFX3	9.77e-04	41	140	3	EFO_0009766
Disease	Anorectal Malformations	INTU NLGN1 FANCB	9.77e-04	41	140	3	C3495676
Disease	alpha wave measurement, electroencephalogram measurement	NOX3 DNAH1	9.81e-04	10	140	2	EFO_0004357, EFO_0006870
Disease	Paranoia	DBH TYK2	1.20e-03	11	140	2	C1456784
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	IL1B VPS13B	1.20e-03	11	140	2	EFO_0007889, EFO_0009366
Disease	Secondary Open Angle Glaucoma	WDR36 MYOC	1.43e-03	12	140	2	C0271148
Disease	nervous system disease (implicated_via_orthology)	ATP1A1 ATP12A	1.43e-03	12	140	2	DOID:863 (implicated_via_orthology)
Disease	Glaucoma, Open-Angle	WDR36 MYOC	1.43e-03	12	140	2	C0017612
Disease	X-12707 measurement	DBH ARSL	1.43e-03	12	140	2	EFO_0800720
Disease	systemic lupus erythematosus (is_marker_for)	SELL TAB3 IL1B	1.45e-03	47	140	3	DOID:9074 (is_marker_for)
Disease	colitis (implicated_via_orthology)	SELL IL1B	1.68e-03	13	140	2	DOID:0060180 (implicated_via_orthology)
Disease	Glaucoma, Primary Open Angle	WDR36 MYOC	1.68e-03	13	140	2	C0339573
Disease	Alcoholic Intoxication, Chronic	THEMIS MPDZ DBH NLGN4X TESK2 IL1B	1.81e-03	268	140	6	C0001973
Disease	abdominal aortic aneurysm (biomarker_via_orthology)	SELL IL1B	1.96e-03	14	140	2	DOID:7693 (biomarker_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	MBTD1 DAND5 TMBIM6 CERT1 TYK2 ARSL CD163L1 NYNRIN SCARB1 PCCB	2.20e-03	713	140	10	EFO_0005689
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	MTOR PKHD1	2.57e-03	16	140	2	DOID:0110861 (implicated_via_orthology)
Disease	sugar consumption measurement	MYOC NBAS PKHD1 VPS13B	2.61e-03	120	140	4	EFO_0010158
Disease	testosterone measurement	ZAN CECR2 DENND2D CSMD3 RYK TYK2 NF1 CGB2 PDE8B NYNRIN SCARB1 ATP12A PCCB DNPEP	3.03e-03	1275	140	14	EFO_0004908
Disease	androstenedione measurement, estrone measurement	OR4D2 BMPER	3.25e-03	18	140	2	EFO_0007970, EFO_0007972
Disease	chronic obstructive pulmonary disease (is_implicated_in)	IL13RA1 RTEL1 IL1B	3.37e-03	63	140	3	DOID:3083 (is_implicated_in)
Disease	sensorineural hearing loss (implicated_via_orthology)	SCARB1 DNAH17	3.63e-03	19	140	2	DOID:10003 (implicated_via_orthology)
Disease	myocardial infarction (implicated_via_orthology)	MAP3K5 MTOR IL1B	3.85e-03	66	140	3	DOID:5844 (implicated_via_orthology)
Disease	Seizures	CACNA1E MPDZ TRRAP ATP1A1 IL1B	3.91e-03	218	140	5	C0036572
Disease	radiation-induced disorder	NOX3 WDR91 NELL2	4.01e-03	67	140	3	EFO_0009565
Disease	end stage renal disease (implicated_via_orthology)	MTOR IL1B	4.02e-03	20	140	2	DOID:783 (implicated_via_orthology)
Disease	Cocaine Dependence	DBH TYK2 SCARB1 LRRC7	4.41e-03	139	140	4	C0600427
Disease	hyperglycemia (biomarker_via_orthology)	IL1B HCRTR2	4.42e-03	21	140	2	DOID:4195 (biomarker_via_orthology)
Disease	status epilepticus (implicated_via_orthology)	MTOR IL1B	4.42e-03	21	140	2	DOID:1824 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELPSECNVGPVMSRQ	nan	181	A8MWP4
LSVRLCPPVSGQAAM	GPT2	371	Q8TD30
CPPVSGQAAMDIVVN	GPT2	376	Q8TD30
IQFANGTEELPVPLM	nan	366	Q9N2K0
ITEQPMCFQRTTPLI	ARSL	261	P51690
ERLQMDGAPPVCQVL	CSMD3	2441	Q7Z407
LSPQDIFQLACMDPA	CACNA1E	1941	Q15878
PLQDLMVRNDTPCGT	DNPEP	411	Q9ULA0
VSPSVCLDQGMQLKP	CPED1	211	A4D0V7
SLLSCFPNVQMLPLD	A4GALT	131	Q9NPC4
ISFRLEPGTTPCQVM	ADGRD1	621	Q6QNK2
VIPLNGTIMPCDAVL	ATP13A3	296	Q9H7F0
ELNVLPFCTQFIPMD	ALDH1L2	101	Q3SY69
MQEEIFGPVLPIVCV	ALDH3A1	331	P30838
AQALGRQLVMLPCSP	DNHD1	1701	Q96M86
LDNCQMTVLGAPPCI	CD163L1	976	Q9NR16
IAMQQLSSRVCPPGV	CECR2	906	Q9BXF3
VVSQIFPCEMIPAVL	AP4E1	156	Q9UPM8
PYQPLIAIGSICGMI	CFAP251	616	Q8TBY9
TVLQPLCLGESPVVM	RAI2	76	Q9Y5P3
ILTMNQTQGLCPEIP	P2RX4	106	Q99571
CPAILNPRMFNIISD	RASA1	906	P20936
CEPIGLQVPPEAVNM	ITGAX	76	P20702
RSMEQIVFPVPGICQ	ITPR3	2131	Q14573
PPVIMGLQLDFCDSS	OR6C65	156	A6NJZ3
ENLTNVMSGFCLPEP	ACACB	1001	O00763
CALIGMSPQVNAVFP	ANO10	571	Q9NW15
VAMICQTLVSPPEGN	CERT1	551	Q9Y5P4
INIIGLAPLCENMPS	LAP3	326	P28838
IVMISTLPFCGPNQI	OR6K3	176	Q8NGY3
LNPQEVIQGMCKAVP	DAND5	91	Q8N907
KMLVPCPQTFQENDL	IL1B	76	P01584
SIVQLALMLPLPFCG	OR4D2	156	P58180
MIQILFTFQLPFCGP	OR4C15	156	Q8NGM1
PQIMIFPEGTCTNRT	LPCAT1	201	Q8NF37
GGMNPQECLPVILDV	ME1	181	P48163
LVMPQGFIAQCPDLN	NELL2	211	Q99435
FPVGFCEINMIELTP	MBTD1	441	Q05BQ5
ISGLQQERSMCTPLP	LRRC7	531	Q96NW7
VPSLMPCQGFCLNVV	GPC2	266	Q8N158
MELLCDAQGTPQPNI	HMCN2	3521	Q8NDA2
SNLCFVGLLSMIDPP	ATP12A	596	P54707
DNLCFVGLISMIDPP	ATP1A1	581	P05023
SCIAVPPLEGFVMNR	FAM91A1	231	Q658Y4
GCPLRMVVQESQLTP	FREM2	706	Q5SZK8
CGTDTMLGQPLQLLP	HERC1	1786	Q15751
LCPNMISTQPQEFVG	LMLN	251	Q96KR4
PQPVASVLIMNCRIG	ITGAE	896	P38570
MCVIPATISNNVPGT	PFKL	521	P17858
MPITINDVPPCISQL	PDE8B	536	O95263
PICFQGPFVQVDELM	CSTF3	626	Q12996
TNCPTLIVMVGLPAR	PFKFB4	36	Q16877
LLACQPQVPSAQVMD	GCGR	16	P47871
IITMCLNSLPDFQIP	KCNS2	201	Q9ULS6
FGPEMPAVQLLLLAC	MYOC	11	Q99972
LPQGMLNSPTICQTF	HERVK_113	161	P63132
CQFLEGSPAMLPVQP	PMS2P5	86	A8MQ11
VIQCEPLSAPDLGIM	SELL	256	P14151
CQMLADNVPVTVPVG	KNTC1	1111	P50748
VCPQNIIDGRLPEVM	NLGN1	116	Q8N2Q7
SIIQVILMLPFPFCG	OR4D6	156	Q8NGJ1
PPIILMTQVDFCVSN	OR6C4	156	Q8NGE1
VAMTDLCPAGPIQAV	FAAP100	771	Q0VG06
EPECGNTPNAMTILL	ITGB5	711	P18084
PEMAIALTPFQGLCG	MPI	136	P34949
LPEACFNGDSLMIIP	NBAS	776	A2RRP1
LPQGMLNSPTICQTF	ERVK-7	161	P63135
LPQGMLNSPTICQTF	ERVK-6	161	Q9BXR3
CFMVPGVLPDTLNTV	IL13RA1	296	P78552
SCVPESMQPFDLLGI	MVB12B	266	Q9H7P6
ETLPPTCQGNLLIMG	NUTM1	856	Q86Y26
VCQLPFGDPCAVQLM	FANCB	276	Q8NB91
TENIERVLSCIPGPM	INTU	241	Q9ULD6
ASGVIPQISLIMGPC	PCCB	186	P05166
LPQGMLNSPTICQTF	ERVK-18	161	Q9QC07
PQAIVMECSTVFPGL	HCRTR2	186	O43614
CPTMTRVLQGVLPAL	CGB2	56	Q6NT52
IPLVPSCAVFITMNP	DNAH1	1671	Q9P2D7
LPQPQQCSLFSVMEL	CNPPD1	386	Q9BV87
VLQIPFITDNPCIMC	BMPER	56	Q8N8U9
LTFGINPFIALMIQP	C2orf83	6	Q53S99
PGNPMLNIIVSTFIF	CASD1	731	Q96PB1
LNAAGMIIPCLGFPQ	DNAH17	56	Q9UFH2
ACTMEVQAPNIQIPS	DBH	211	P09172
VPFCGQEVTDPVQMI	GIMD1	116	P0DJR0
VCFVSNLFPPMLTVN	HLA-DMA	146	P28067
ILPVMQSLCPDGQRD	ABCA2	66	Q9BZC7
CIAVNPSILPTAFMG	TMBIM6	106	P55061
IQEPNTFPAILRSMC	GNS	126	P15586
SPVLNAFVMPICLPE	MASP1	561	P48740
AFVMPICLPEGPQQE	MASP1	566	P48740
ICLPEGPQQEGAMVI	MASP1	571	P48740
VVLICPQDGMEAIPN	LSM7	81	Q9UK45
ANVREPICGFTPLME	ANKS3	161	Q6ZW76
QMGLVIEPPQCQFAQ	EFHB	211	Q8N7U6
GSGEAMLQLIPPFQC	C6orf89	286	Q6UWU4
FMCAQLPNPVLDSIS	EHD1	136	Q9H4M9
VPCLSTRLINPENMG	SACS	1436	Q9NZJ4
IAQPINCPDELFAVM	RYK	561	P34925
MQIVQGFPADAPLCA	DSCR10	1	P59022
DGCLQFLVPMLQDFP	HCN2	381	Q9UL51
PLLFTPVCVMLNSNV	NLGN4X	11	Q8N0W4
LQVTCQQMPPFICGA	CEBPZ	591	Q03701
DFPLNMNPGILVTCA	FPGT	166	O14772
LATVCCPTPFMVGVQ	DENND2D	296	Q9H6A0
MACPALGLEALQPLQ	LIMCH1	1	Q9UPQ0
PVLGLVQNMSVFQCP	NUBPL	231	Q8TB37
PPVMLLLQLDFCASN	OR6C75	156	A6NL08
VSALCLMAPNSQLPF	NYNRIN	1146	Q9P2P1
FLIPIVLISQMPFCG	OR11H1	171	Q8NG94
VLISQMPFCGPNIID	OR11H1	176	Q8NG94
FLIPIVLISQMPFCG	OR11H12	171	B2RN74
VLISQMPFCGPNIID	OR11H12	176	B2RN74
PVCLSRELGVMQPGQ	OTOG	2686	Q6ZRI0
SLGLKCVQFLPQVMP	MTOR	981	P42345
CVQFLPQVMPTFLNV	MTOR	986	P42345
PQVMPTFLNVIRVCD	MTOR	991	P42345
ELMQPNFELLLGPIC	MAP3K5	236	Q99683
EMQIPFPVCLENPHI	RTEL1	491	Q9NZ71
IPVNQDCILDGFPMT	SPEF2	716	Q9C093
AICFGPTLMPVPEIQ	SRGAP1	656	Q7Z6B7
PTLMPVPEIQDQVSC	SRGAP1	661	Q7Z6B7
PEIPEGVVSQCMLQN	TAB3	21	Q8N5C8
KTELSQAFPVGCMQP	RFX3	696	P48380
QAFPVGCMQPVLETG	RFX3	701	P48380
GCMQPVLETGVQPSL	RFX3	706	P48380
PPETCQMEAGSLFLL	SPATA31A6	306	Q5VVP1
DCQFLEGSPAMLPVQ	PMS2P2	256	O95744
MPALESLCLQGPLVT	FBXL12	251	Q9NXK8
PPETCQMEAGSLFLL	SPATA31A7	306	Q8IWB4
DPDVQLVMCILPSNQ	PIWIL4	541	Q7Z3Z4
PQLILVNMASFPECT	MRRF	141	Q96E11
PVTGIPMNCSVKLQL	SCARB1	376	Q8WTV0
PGMVSRILFPDQVAC	SLC5A11	326	Q8WWX8
PMVFVDDQLPCNVTF	PKHD1	1516	P08F94
KMAPGQYILVQCPAI	NOX3	316	Q9HBY0
NTRGQIPPLVTTDCM	SEC24D	286	O94855
IPPLVTTDCMIQDQG	SEC24D	291	O94855
PEQLIPFAGICMFIL	SLC28A2	171	O43868
NVLPFCSQFIPMEII	ALDH1L1	81	O75891
QLGPLMCQFGLPAEA	ADRM1	351	Q16186
LCAGQVTALPVNSPM	CHGA	11	P10645
FLEMPLRQSGLCQPE	C11orf16	371	Q9NQ32
LPQGMLNSPTICQTF	ERVK-25	161	P63136
AGPLTFNEMIQPVCL	TMPRSS3	311	P57727
PPETCQMEAGSLFLL	SPATA31A3	306	Q5VYP0
QIEGCESLQPFELPM	THEMIS	66	Q8N1K5
VNQMAVCPGNAVEPL	MPDZ	1436	O75970
PPETCQMEAGSLFLL	SPATA31A5	306	Q5VU36
RDNMSVILICFPNAP	PPM1A	281	P35813
QVPGQSSIFTMCELP	TMEM94	771	Q12767
ATCPIVPGQEMIIEI	PATJ	1426	Q8NI35
PIGLNMCTPGDQELI	RYR3	3376	Q15413
PCIAEFMPILGTNLN	TNPO2	701	O14787
NILSPAGQIFMCPLC	ZBTB18	361	Q99592
LPQGMLNSPTICQTF	ERVK-10	161	P10266
LPQGMLNSPTICQTF	ERVK-8	161	P63133
RPEMFIIGAQPVCSQ	WNT5B	36	Q9H1J7
LPIAMALANVVPCSQ	NF1	1221	P21359
LPQGMLNSPTICQTF	ERVK-11	161	Q9UQG0
VYIGGMPCELLIPQS	PKHD1L1	191	Q86WI1
PPNMGQDICFVLLAL	TGM5	516	O43548
DVVCMSLANVPPGEQ	SF3B3	586	Q15393
DCQNMLFPIKPGETQ	ZNF717	161	Q9BY31
MVGECQFAVPVPKPL	TOPAZ1	1016	Q8N9V7
GQTSMPGTLVLCLPQ	VPS13B	1106	Q7Z7G8
MCQPVARGFVVLPIT	TMEM130	116	Q8N3G9
NMGCAVINPEPITLT	TASOR2	1041	Q5VWN6
MVGDCPPDFLQLTFN	TESK2	276	Q96S53
DLCLAMAVQTPVPTA	RIPOR1	771	Q6ZS17
NFLSVLFQCMPVPVI	WDR91	161	A4D1P6
LFQCMPVPVILNFDA	WDR91	166	A4D1P6
MVAVAQQCGPFLLPC	TRRAP	1051	Q9Y4A5
CLPQPGETSNLIIMR	TYK2	551	P29597
PSIVMLPGTCQTQDV	WDR36	711	Q8NI36
VVAMGFILINPGTCP	ZAN	521	Q9Y493